checkAd

    EQS-Adhoc  520  0 Kommentare HOCHDORF Holding AG: Forward Integration in Baby Care

    EQS Group-Ad-hoc: HOCHDORF Holding AG / Key word(s): Letter of Intent
    HOCHDORF Holding AG: Forward Integration in Baby Care

    25.07.2016 / 07:00
    Release of an ad hoc announcement pursuant to Art. 53 KR.


    ---------------------------------------------------------------------------

    HOCHDORF Group Press Release: Forward Integration in Baby Care

    Forward integration with Pharmalys Laboratories SA under examination

    Hochdorf, 25 July 2016 - HOCHDORF Holding Ltd previously announced the
    integration of downstream stages of the value creation stream as one of its
    strategic aims, particularly for the international market. In the area of
    Baby Care there is now mutual interest with Pharmalys Laboratories SA in
    pursuing an integration with the HOCHDORF Group. A Memorandum of
    Understanding has been signed to this effect.

    HOCHDORF Holding Ltd does not currently supply the end consumer market in
    the Baby Care area through its subsidiary HOCHDORF Swiss Nutrition Ltd.
    This would change with a majority shareholding in Pharmalys Laboratories
    SA, based in Baar (ZG).

    Active in 42 countries
    The Pharmalys Group has a staff of more than 500 direct and indirect
    employees around the world. The company markets infant nutrition under the
    Primalac brand; it also markets infant nutrition and cereals under the
    Swisslac brand. Its products are available in 42 countries in Europe, Asia,
    Africa and the Middle East. Pharmalys Laboratories SA is a company that has
    shown rapid growth: a HOCHDORF customer since 2008, Pharmalys expects to
    achieve sales of CHF 70 million this year with a two-figure increase in the
    EBIT Margins. The company is seeking to double its turnover and EBIT in the
    next two years.

    "We have achieved a very rapid growth in recent years with HOCHDORF
    products and we would like to continue in this vein. An integration can
    guarantee our access to the high-quality HOCHDORF products. In return
    HOCHDORF will receive direct access to consumers in our highly attractive
    markets," explained founder and CEO of the Pharmalys Group, Amir Mechria.

    As part of this transaction, HOCHDORF will secure a call option for
    majority share in the Dubai-based Phamena Ltd, which is also part of the
    Pharmalys Group. Phamena Ltd operates exclusively in the Libyan market.

    Dr Thomas Eisenring, CEO of the HOCHDORF Group is delighted with the
    Memorandum of Understanding: "The HOCHDORF Group is striving towards
    forward integration in the area of infant nutrition. An association with
    one of our largest customers is exactly in keeping with our strategy. We
    have enjoyed excellent collaboration with Pharmalys for years," he said.

    The next step will be to negotiate a purchase agreement. Adoption of the
    purchase agreement will depend on a variety of conditions. It may not be
    derived from either the Memorandum of Understanding or this press release
    that HOCHDORF Holding Ltd has acquired a minority or majority shareholding
    in Pharmalys Laboratories SA either now or in the future.

    End of ad hoc announcement
    Additional features:


    Document: http://n.eqs.com/c/fncls.ssp?u=EFBURFFCIK
    Document title: HOCHDORF Group Press Release Forward Integration

    ---------------------------------------------------------------------------

    25.07.2016 News transmitted by Tensid EQS AG. www.eqs.com

    ---------------------------------------------------------------------------


    Information and Explanation of the Issuer to this News:

    In 2015 the HOCHDORF Group, which is headquartered in Hochdorf, generated a
    consolidated gross sales revenue of CHF 551.2 million. It is one of the
    leading foodstuff companies in Switzerland, with more than 625 employees as
    at 31 December 2015. Made from such natural ingredients as milk, wheat
    germ, and oilseeds, HOCHDORF products have been contributing to the health
    and well-being of the young and old alike since 1895. Our customers include
    the food industry and wholesalers and retailers. Our products are sold in
    more than 90 countries. HOCHDORF stock is traded on the SIX Swiss Exchange
    in Zurich (ISIN CH0024666528).


    ---------------------------------------------------------------------------

    Language: English
    Company: HOCHDORF Holding AG
    Siedereistrasse 9
    6281 Hochdorf
    Switzerland
    Phone: +41 41 914 65 65
    Fax: +41 41 914 66 66
    E-mail: hochdorf@hochdorf.com
    Internet: www.hochdorf.com
    ISIN: CH0024666528
    Listed: Foreign Exchange(s) SIX


    End of News EQS Group News Service
    ---------------------------------------------------------------------------

    485325 25.07.2016


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc HOCHDORF Holding AG: Forward Integration in Baby Care EQS Group-Ad-hoc: HOCHDORF Holding AG / Key word(s): Letter of Intent HOCHDORF Holding AG: Forward Integration in Baby Care 25.07.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. …

    Schreibe Deinen Kommentar

    Disclaimer